Form 8-K - Current report:
SEC Accession No. 0000950170-24-066246
Filing Date
2024-05-30
Accepted
2024-05-30 07:09:33
Documents
14
Period of Report
2024-05-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cgc-20240530.htm   iXBRL 8-K 46395
2 EX-99.1 cgc-ex99_1.htm EX-99.1 864222
3 GRAPHIC img62664582_0.jpg GRAPHIC 93204
4 GRAPHIC img62664582_1.jpg GRAPHIC 13543
  Complete submission text file 0000950170-24-066246.txt   1225514

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cgc-20240530.xsd EX-101.SCH 31032
17 EXTRACTED XBRL INSTANCE DOCUMENT cgc-20240530_htm.xml XML 4512
Mailing Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8
Business Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8 855-558-9333
Canopy Growth Corp (Filer) CIK: 0001737927 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38496 | Film No.: 241000693
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)